These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2010934)
1. Randomized clinical trials: enough bang for the buck? Strandness DE J Vasc Surg; 1991 Apr; 13(4):544-8. PubMed ID: 2010934 [No Abstract] [Full Text] [Related]
2. Can registries offer an insight into likely outcomes for newly introduced treatment techniques? Thomas SM Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):493-4. PubMed ID: 17616406 [No Abstract] [Full Text] [Related]
3. Non-commercial randomised clinical trials need money for meetings and travel expenses. Kunkler IH BMJ; 2003 Dec; 327(7427):1349. PubMed ID: 14656866 [No Abstract] [Full Text] [Related]
4. Pharmaceutical company-sponsored drug trials: what are we to believe? Shekelle P J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207 [No Abstract] [Full Text] [Related]
5. Data bases of clinical trials. Albrich JM N Engl J Med; 1999 Jan; 340(1):65-6. PubMed ID: 9882223 [No Abstract] [Full Text] [Related]
6. Association between research sponsorship and study outcome in plastic surgery literature. Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933 [TBL] [Abstract][Full Text] [Related]
7. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?]. Als-Nielsen BE; Chen W; Gluud CN; Gluud LL Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406 [No Abstract] [Full Text] [Related]
8. Outcome reporting bias in government-funded RCTs. Moja PL; Moschetti I; D'Amico R CMAJ; 2005 Mar; 172(7):857; author reply 857. PubMed ID: 15795393 [No Abstract] [Full Text] [Related]
9. Clinician-trialist rounds: 12. When your grant gets turned down--part 2: resurrection. Szatmari P; Sackett DL Clin Trials; 2012 Oct; 9(5):660-3. PubMed ID: 23060324 [No Abstract] [Full Text] [Related]
17. Complementary and alternative medicine in outcomes research. Riley D; Berman B Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498 [No Abstract] [Full Text] [Related]
18. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials. Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489 [TBL] [Abstract][Full Text] [Related]
19. Industry sponsorship and selection of comparators in randomized clinical trials. Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879 [TBL] [Abstract][Full Text] [Related]
20. International collaboration, funding and association with burden of disease in randomized controlled trials in Africa. Swingler GH; Pillay V; Pienaar ED; Ioannidis JP Bull World Health Organ; 2005 Jul; 83(7):511-7. PubMed ID: 16175825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]